Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Tschirren

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Vox Sanguinis|January 1, 1978
Red cells and gelatin as the core of a unified program for the national procurement of blood components and derivatives. Prediction, performance, and impact on supply of albumin and factor VIIIP Lundsgaard-Hansen, U Bucher, B Tschirren, et al.
Vox Sanguinis|January 1, 1979
To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?J A Collins, M S Litwin, H Lutz, et al.
Helvetica Medica Acta. Supplementum|June 1, 1970
[Swine liver perfusion--therapy of acute severe liver failure]R G Herz, A Halpern, J Bircher, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Vox Sanguinis|January 1, 1978
Red cells and gelatin as the core of a unified program for the national procurement of blood components and derivatives. Prediction, performance, and impact on supply of albumin and factor VIIIP Lundsgaard-Hansen, U Bucher, B Tschirren, et al.
Vox Sanguinis|January 1, 1979
To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?J A Collins, M S Litwin, H Lutz, et al.
Helvetica Medica Acta. Supplementum|June 1, 1970
[Swine liver perfusion--therapy of acute severe liver failure]R G Herz, A Halpern, J Bircher, et al.
Pageof 3